Page last updated: 2024-08-23

radium and mdv 3100

radium has been researched along with mdv 3100 in 60 studies

Research

Studies (60)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	40 (66.67)	24.3611
2020's	20 (33.33)	2.80

Authors

Authors	Studies
Agarwal, N; Sonpavde, G; Sternberg, CN	1
Beuzeboc, P; Goldwasser, F; Ropert, S; Zerbib, M	1
Lewis, B; Pal, SK; Sartor, O	1
Culine, S; Ouzaid, I; Pouessel, D; Ravery, V	1
Agarwal, N; Bellmunt, J; DiLorenzo, G; Sonpavde, G; Vogelzang, NJ; Zhang, TY	1
Kellokumpu-Lehtinen, P; Tammela, T	1
Joshua, AM; Leibowitz-Amit, R	1
D'Amico, AV	1
Bahl, A	1
Blank, PR; Puri, D; Szucs, TD	1
Gartrell, BA; Saad, F	1
Alcaraz, A; Caffo, O; da Silva, FC; Hammerer, P; Merseburger, AS; Roumeguère, T; Rozet, F	1
Beer, TM; Graff, JN	2
Scagliotti, GV; Tucci, M; Vignani, F	1
Dan, TD; Den, RB; Dicker, AP; Eldredge-Hindy, HB; Gomella, LG; Hoffman-Censits, J; Hurwitz, MD; Kelly, WK; Lallas, CD; Lin, J; Trabulsi, EJ	1
Attard, G; de Bono, JS; Lorente, D; Mateo, J; Perez-Lopez, R	1
Crawford, ED; Higano, CS; Hussain, M; Petrylak, DP; Shore, ND	1
Bertaglia, V; Buttigliero, C; Di Maio, M; Scagliotti, GV; Tucci, M; Vignani, F	1
Barkin, J; Mak, V	1
Ackermann, CJ; Gillessen, S; Hager, S; Joerger, M; Omlin, A	1
Aarts, MJ; Badrising, SK; Bergman, AM; Coenen, JL; de Jong, IJ; Gelderblom, H; Haanen, JB; Hamberg, P; Kerver, ED; Los, M; van den Berg, HP; van den Eertwegh, AJ; van der Noort, V; van Oort, IM; van Voorthuizen, T; Vrijaldenhoven, S	1
Concepcion, RS; Crawford, ED; Finkelstein, SE; Gomella, LG; Keane, TE; Koo, PJ; O'Sullivan, JM; Petrylak, DP; Saad, F; Shore, N; Sieber, P; Slovin, SF; Stone, NN; Tombal, B; Vogelzang, NJ; Yu, EY	1
Armstrong, A; Balk, M; Brown, B; Bui, C; Chambers, J; Deangelis, J; Fitch, K; Flanders, S; Sawhney, TG	1
Izumi, K; Kadono, Y; Kitagawa, Y; Konaka, H; Mizokami, A	1
Hinz, S	1
Baka, A; de Meijer, C; Gaultney, JG; Leliveld-Kors, AM; Noordzij, W; Peters, ML; van den Berg, PH; van den Bosch, J; Wyndaele, D	1
Grimm, MO; von Rundstedt, FC; Winter, BM	1
De Bono, J; Sumanasuriya, S	1
Agrawal, M; Almeida, F; Brown, A; Dicker, AP; Fernandez, DC; Garcia, JA; Gratt, J; Iagaru, A; Lutzky, J; Morris, MJ; Petrenciuc, O; Sartor, O; Shore, ND; Smith, MR; Sweeney, C; Vogelzang, NJ; Wong, YN	1
Abrahamsson, M; Falkenius, J; Henriksson, R; Lindquist, M; Lööv, SÅ; Norin, S; Öhman, D	1
Heidenreich, A; Nilsson, S; Parker, C; Shore, N	1
Baumgart, SJ; Haendler, B; Nevedomskaya, E	1
Mulders, PFA; Niepel, D; Saad, F; Sternberg, CN; Tombal, BF	1
Canelón Castillo, E; Díez Farto, S; Jiménez Romero, ME; Navarro Serrato, JS; Revelo Cadena, I	1
Franklin, GE; Rathbun, JT	1
Bryce, AH; Dorff, TB; Groshen, S; Ji, L; Quinn, DI; Wong, W; Yap, KK	1
Buttigliero, C; Caffo, O; Cavaliere, C; D'aniello, C; Di Maio, M; Facchini, G; Kinspergher, S; Maines, F; Rizzo, M; Rossetti, S; Scagliotti, GV; Tucci, M; Veccia, A	1
Buonerba, C; Di Lorenzo, G; Fizazi, K; Pagliuca, M	1
Badrising, SK; Beeker, A; Bergman, AM; Celik, F; Coenen, JLLM; Haanen, JB; Hamberg, P; Lam, MGEH; Loosveld, OJL; Louhanepessy, RD; Oostdijk, A; van der Noort, V; Vegt, E; Wagenaar, N; Zuetenhorst, H; Zwart, W	1
Agarwal, N; Batten, J; Boucher, K; Gupta, S; Haaland, B; Hahn, AW; Hawks, J; Hoffman, JM; Maughan, BL; Morton, K; Nachaegari, G; Nussenzveig, R; Santos, VS; Thorley, J; Wang, X	1
Casadei, C; Cursano, MC; De Giorgi, U; Iuliani, M; Paganelli, G; Santini, D; Stellato, M; Tonini, G	1
George, DJ; Higano, CS; Jiao, X; Kalinovsky, J; Miller, K; Saad, F; Sartor, O; Shore, N; Sternberg, CN; Tangirala, K; Tombal, B	1
Abou Chakra, M; Dellis, A; Moussa, M; Papatsoris, A; Sryropoulou, D	1
Harrelson, SS; Mariados, NF; Schellhammer, PF; Shore, ND; Tutrone, RF	1
Abouassaly, R; Bryk, DJ; Ericson, K; Fascelli, M; Haywood, SC; Khanna, A; Murthy, PB; O'Connor, LP; Yerram, NK	1
Ahmed, ME; Badawy, M; Joshi, VB; Karnes, RJ; Kendi, AT; Kwon, ED; Lowe, V; Pagliaro, LC; Thorpe, MP	1
Amling, CL; Aronson, WJ; Cooperberg, MR; De Hoedt, AM; Freedland, SJ; Howard, LE; Kane, CJ; Klaassen, Z; Polascik, TJ; Terris, MK; Vidal, AC; Zhao, H	1
Albany, C; Dawson, NA; Higano, CS; Mehlhaff, BA; Nordquist, LT; Patel, KR; Petrylak, DP; Quinn, DI; Sartor, O; Siegel, J; Trandafir, L; Vaishampayan, UN; Wagner, VJ	1
Aben, KKH; Bergman, AM; Coenen, JLLM; de Wit, R; Gerritsen, WR; Kuppen, MCP; Mehra, N; Somford, DM; Uyl-de Groot, CA; van den Bergh, ACM; van den Eertwegh, AJM; van Moorselaar, RJA; van Oort, IM; Westgeest, HM	1
Alongi, F; Alongi, P; Baldari, S; Borsatti, E; Bortolus, R; Caffo, O; Cortesi, E; Costa, RP; De Giorgi, U; De Vincentis, G; Donner, D; Facchini, G; Fanti, S; Frantellizzi, V; Galli, L; Lo Re, G; Masini, C; Monari, F; Morabito, A; Pignata, S; Pinto, C; Salgarello, M; Sbrana, A; Spada, M; Tucci, M; Zichi, C	1
Basch, EM; Brower, B; Crona, DJ; Dunn, MW; Godley, PA; Khandani, AH; Kim, SI; Milowsky, MI; Morgan, KP; Rose, TL; Szeto, AH; Whang, YE	1
Alibhai, SMH; Breunis, H; Emmenegger, U; Feng, G; Fleshner, N; Gregg, R; Hansen, A; Joshua, A; Timilshina, N; Tomlinson, G; Warde, P	1
Agarwal, N; Boucher, K; Haaland, B; Hahn, AW; Hoffman, JM; Kessel, A; Kohli, M; Maughan, BL; McFarland, TR; Morton, K; Nussenzveig, R; Sayegh, N; Sirohi, D; Swami, U	1
Agarwal, N; Bruno, A; George, D; Guo, H; Higano, CS; Jiao, X; Miller, K; Saad, F; Sandström, P; Sartor, O; Shore, N; Sternberg, CN; Tombal, B; Verholen, F	1
Maughan, BL	1
Anderson, M; Cao, Y; Chang, M; Rojas, V; Trieu, J; Varada, N; Vogelzang, NJ	1
Alonso-Gordoa, T; Bonfill, T; Borrega, P; Carles, J; Collado, R; Gallardo, E; Garcías de España, C; Garde, J; González-Del-Alba, A; Malfettone, A; Mellado, B; Méndez-Vidal, MJ; Morales-Barrera, R; Paredes, P; Piulats, JM; Reig, O; Sampayo-Cordero, M; Suárez, C; Vázquez, S	1
Alhoniemi, E; Haendler, B; Käkönen, SM; Knuuttila, M; Mumberg, D; Schatz, CA; Schlicker, A; Scholz, A; Sjöholm, B; Suominen, MI; Vääräniemi, J	1

Reviews

30 review(s) available for radium and mdv 3100

Article	Year
Novel molecular targets for the therapy of castration-resistant prostate cancer. European urology, 2012, Volume: 61, Issue:5 Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic	2012
[Management of metastatic castration-resistant prostate cancer following docetaxel]. Bulletin du cancer, 2012, Volume: 99 Suppl 1 Topics: Abiraterone Acetate; Androgen Antagonists; Androstadienes; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Docetaxel; Humans; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms; Radioisotopes; Radium; Taxoids; Treatment Failure	2012
Management of docetaxel failures in metastatic castrate-resistant prostate cancer. The Urologic clinics of North America, 2012, Volume: 39, Issue:4 Topics: Androstenes; Androstenols; Antineoplastic Agents; Benzamides; Docetaxel; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Taxoids; Treatment Failure	2012
[Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:1 Topics: Androstenes; Androstenols; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Denosumab; Disease-Free Survival; France; Humans; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Tissue Extracts; Treatment Outcome	2013
[Novel drugs provide better therapy for prostate cancer]. Duodecim; laaketieteellinen aikakauskirja, 2013, Volume: 129, Issue:9 Topics: Androstenes; Androstenols; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Denosumab; Gonadotropin-Releasing Hormone; Humans; Male; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatic Neoplasms; Radioisotopes; Radium; Taxoids	2013
The changing landscape in metastatic castration-resistant prostate cancer. Current opinion in supportive and palliative care, 2013, Volume: 7, Issue:3 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Antineoplastic Agents; Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines; Quality of Life; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Taxoids	2013
Metastatic castration-resistant prostate cancer. Part 1: the challenges of the disease and its treatment. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2013, Volume: 17 Suppl 1 Topics: Alpha Particles; Androstenes; Androstenols; Antineoplastic Agents; Benzamides; Cancer Vaccines; Chlorides; Docetaxel; Humans; Male; Mitoxantrone; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Taxoids; Tissue Extracts	2013
Pathologic fracture in patients with metastatic prostate cancer. Current opinion in urology, 2014, Volume: 24, Issue:6 Topics: Androstenes; Anilides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pyridines; Radioisotopes; Radium; Zoledronic Acid	2014
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy? World journal of urology, 2015, Volume: 33, Issue:8 Topics: Androstenes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Benzamides; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Taxoids; Tissue Extracts	2015
Pharmacotherapeutic management of metastatic, castration-resistant prostate cancer in the elderly: focus on non-chemotherapy agents. Drugs & aging, 2014, Volume: 31, Issue:12 Topics: Aged; Androstenes; Benzamides; Health Services for the Aged; Humans; Male; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Tissue Extracts	2014
Metastatic castration-resistant prostate cancer: time for innovation. Future oncology (London, England), 2015, Volume: 11, Issue:1 Topics: Androstenes; Antibodies, Monoclonal, Humanized; Benzamides; Clinical Trials, Phase III as Topic; Denosumab; Drug Resistance, Neoplasm; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Receptors, Androgen; Signal Transduction; Taxoids; Tissue Extracts	2015
Sequencing of agents in castration-resistant prostate cancer. The Lancet. Oncology, 2015, Volume: 16, Issue:6 Topics: Abiraterone Acetate; Androstenes; Benzamides; Docetaxel; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Taxoids; Tissue Extracts; Treatment Outcome	2015
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:6 Topics: Androgen Receptor Antagonists; Androstenes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Cost-Benefit Analysis; Denosumab; Diphosphonates; Enzyme Inhibitors; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Pain; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Spinal Cord Compression; Zoledronic Acid	2015
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies. The Journal of urology, 2015, Volume: 194, Issue:6 Topics: Androgen Antagonists; Androstenes; Antineoplastic Agents; Benzamides; Disease Progression; Docetaxel; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate; Taxoids; Tissue Extracts	2015
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. Cancer treatment reviews, 2016, Volume: 44 Topics: Androstenes; Anilides; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Dasatinib; Denosumab; Diphosphonates; Docetaxel; Humans; Imidazoles; Male; Mitoxantrone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines; Radioisotopes; Radium; Taxoids; Zoledronic Acid	2016
Anti-tumour activity of platinum compounds in advanced prostate cancer-a systematic literature review. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:6 Topics: Androgen Receptor Antagonists; Benzamides; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Humans; Male; Nitriles; Phenylthiohydantoin; Platinum Compounds; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; Treatment Outcome	2016
The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). Urology, 2017, Volume: 104 Topics: Androgens; Androstenes; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Disease Progression; Humans; Immunotherapy; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitriles; Phenylthiohydantoin; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2017
Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines. International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:8 Topics: Abiraterone Acetate; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Disease Progression; Docetaxel; Humans; Japan; Male; Neoplasm Recurrence, Local; Nitriles; Phenylthiohydantoin; Prognosis; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids	2017
[Monitoring of treatment for metastatic castration-resistant prostate cancer]. Aktuelle Urologie, 2017, Volume: 48, Issue:3 Topics: Abiraterone Acetate; Benzamides; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Docetaxel; Humans; Male; Neoplastic Cells, Circulating; Nitriles; Outcome and Process Assessment, Health Care; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids	2017
[Radium-223 dichloride in patients with castration-refractory prostate cancer]. Der Urologe. Ausg. A, 2017, Volume: 56, Issue:11 Topics: Androstenes; Benzamides; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Denosumab; Humans; Male; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retreatment	2017
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise. Cold Spring Harbor perspectives in medicine, 2018, 06-01, Volume: 8, Issue:6 Topics: Androgen Receptor Antagonists; Androstenes; Antigens, Surface; Benzamides; Bridged-Ring Compounds; Drug Discovery; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Receptors, Androgen; Taxoids; Tissue Extracts	2018
Current approaches to incorporation of radium-223 in clinical practice. Prostate cancer and prostatic diseases, 2018, Volume: 21, Issue:1 Topics: Androstenes; Benzamides; Bone Neoplasms; Docetaxel; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Receptors, Androgen; Taxoids; Treatment Outcome	2018
Recent Advances in Prostate Cancer Treatment and Drug Discovery. International journal of molecular sciences, 2018, May-04, Volume: 19, Issue:5 Topics: Abiraterone Acetate; Androgen Receptor Antagonists; Antigens, Surface; Benzamides; Drug Discovery; Glutamate Carboxypeptidase II; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prostate; Prostatic Neoplasms; Radioisotopes; Radium; Receptors, Androgen; Thiohydantoins	2018
The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer. Cancer treatment reviews, 2018, Volume: 68 Topics: Abiraterone Acetate; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Clinical Trials, Phase III as Topic; Denosumab; Diphosphonates; Humans; Imidazoles; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Taxoids; Zoledronic Acid	2018
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. Cancer treatment reviews, 2019, Volume: 74 Topics: Abiraterone Acetate; Benzamides; Humans; Male; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; Tissue Extracts	2019
The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer. Drugs, 2019, Volume: 79, Issue:4 Topics: Androgen Antagonists; Androstenes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Benzamides; Clinical Trials as Topic; Docetaxel; Humans; Immunotherapy; Male; Molecular Targeted Therapy; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Retrospective Studies; Taxoids; Thiohydantoins; Tissue Extracts	2019
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review. Critical reviews in oncology/hematology, 2020, Volume: 146 Topics: Androstenes; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Docetaxel; Humans; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome; Tumor Microenvironment	2020
Pharmacotherapeutic strategies for castrate-resistant prostate cancer. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:12 Topics: Abiraterone Acetate; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prednisone; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; Tissue Extracts	2020
Contemporary management of advanced prostate cancer: an evolving landscape. Clinical advances in hematology & oncology : H&O, 2021, Volume: 19, Issue:2 Topics: Adenocarcinoma; Androstenes; Benzamides; Clinical Trials as Topic; Combined Modality Therapy; Diagnostic Imaging; Disease Management; Docetaxel; Humans; Male; Multicenter Studies as Topic; Nitriles; Phenylthiohydantoin; Precision Medicine; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radiotherapy, Adjuvant; Radium; Taxoids; Therapies, Investigational	2021
Lower Fracture Rates in Patients Treated with Radium-223, Abiraterone or Enzalutamide, When Given Concurrently with Bone Health Agents: A Real-World Analysis. Clinical genitourinary cancer, 2022, Volume: 20, Issue:5 Topics: Abiraterone Acetate; Aged; Androgen Antagonists; Androgens; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Density; Denosumab; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Zoledronic Acid	2022

Trials

8 trial(s) available for radium and mdv 3100

Article	Year
Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies. American journal of clinical oncology, 2017, Volume: 40, Issue:4 Topics: Aged; Androgen Antagonists; Androstenes; Antineoplastic Agents; Benzamides; Blood Cells; Combined Modality Therapy; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2017
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. The oncologist, 2018, Volume: 23, Issue:2 Topics: Aged; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Nitriles; Phenylthiohydantoin; Prognosis; Radium; Survival Rate	2018
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 05-01, Volume: 26, Issue:9 Topics: Aged; Aged, 80 and over; Androgen Receptor Antagonists; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Chemoradiotherapy; Collagen Type I; Humans; Male; Middle Aged; Nitriles; Peptides; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Rate	2020
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer. Clinical genitourinary cancer, 2020, Volume: 18, Issue:5 Topics: Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radium	2020
A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide. ESMO open, 2021, Volume: 6, Issue:2 Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Tomography, X-Ray Computed	2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer. PloS one, 2021, Volume: 16, Issue:6 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Chemoradiotherapy; Follow-Up Studies; Humans; Male; Nitriles; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Rate	2021
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. The oncologist, 2021, Volume: 26, Issue:12 Topics: Aged; Benzamides; Castration; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium	2021
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial. European journal of cancer (Oxford, England : 1990), 2022, Volume: 173 Topics: Abiraterone Acetate; Androgen Antagonists; Benzamides; Bone Neoplasms; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Receptors, Androgen	2022

Other Studies

22 other study(ies) available for radium and mdv 3100

Article	Year
Management of castrate resistant prostate cancer-recent advances and optimal sequence of treatments. Current urology reports, 2013, Volume: 14, Issue:3 Topics: Androstenes; Androstenols; Anilides; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Disease-Free Survival; Humans; Imidazoles; Ipilimumab; Male; Naphthalenes; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines; Quinolines; Quinolones; Radioisotopes; Radium; Taxoids; Thionucleotides; Tissue Extracts	2013
US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Feb-01, Volume: 32, Issue:4 Topics: Androstenes; Androstenols; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Denosumab; Diphosphonates; Docetaxel; Drug Approval; Drugs, Investigational; Estramustine; Goserelin; Humans; Imidazoles; Male; Mitoxantrone; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatic Neoplasms; Radioisotopes; Radium; Taxoids; Tissue Extracts; United States; United States Food and Drug Administration; Zoledronic Acid	2014
The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus. European journal of clinical pharmacology, 2014, Volume: 70, Issue:8 Topics: Algorithms; Androstenes; Androstenols; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Cancer Vaccines; Humans; Immunosuppressive Agents; Ipilimumab; Lupus Erythematosus, Systemic; Male; Melanoma; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Skin Neoplasms; Tissue Extracts	2014
Singapore Cancer Network (SCAN) Guidelines for the Management of Advanced Castrate-Resistant Prostate Cancer. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10 Topics: Adenocarcinoma; Androgen Antagonists; Androstenes; Antineoplastic Agents; Benzamides; Cancer Vaccines; Docetaxel; Gonadotropin-Releasing Hormone; Humans; Ketoconazole; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Singapore; Taxoids; Tissue Extracts	2015
The primary care physician's role in the monitoring and management of the potential sequelae of the medical treatment of prostate cancer: early and late. The Canadian journal of urology, 2016, Volume: 23, Issue:Suppl 1 Topics: Abiraterone Acetate; Androgen Antagonists; Antineoplastic Agents; Benzamides; Denosumab; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Nitriles; Phenylthiohydantoin; Physicians, Primary Care; Professional Role; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Time Factors	2016
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer. Oncology, 2016, Volume: 91, Issue:5 Topics: Abdominal Neoplasms; Abiraterone Acetate; Aged; Antineoplastic Agents; Benzamides; Bone Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Humans; Lymphatic Metastasis; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retreatment; Retrospective Studies; Survival Rate; Taxoids	2016
Docetaxel chemotherapy in metastatic castration-resistant prostate cancer: cost of care in Medicare and commercial populations. Current medical research and opinion, 2017, Volume: 33, Issue:6 Topics: Aged; Androstenes; Benzamides; Docetaxel; Drug Costs; Health Care Costs; Humans; Male; Medicare; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; United States	2017
Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer. Applied health economics and health policy, 2018, Volume: 16, Issue:1 Topics: Androstenes; Antineoplastic Agents; Benzamides; Cost-Benefit Analysis; Health Care Costs; Humans; Male; Markov Chains; Netherlands; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Quality-Adjusted Life Years; Radium; Treatment Failure	2018
[Register for new drugs in cancer care provides a picture of how the drugs are used in the daily clinical practice]. Lakartidningen, 2017, 11-06, Volume: 114 Topics: Androstenes; Antineoplastic Agents; Benzamides; Bevacizumab; Breast Neoplasms; Colorectal Neoplasms; Drug Utilization; Humans; Ipilimumab; Male; Melanoma; Neoplasms; Nitriles; Palliative Care; Phenylthiohydantoin; Pilot Projects; Prostatic Neoplasms; Radium; Registries; Survival Rate; Sweden; Withholding Treatment	2017
Clinical case of a patient undergoing radium-223 treatment following treatment with abiraterone acetate and enzalutamide. Experimental oncology, 2018, Volume: 40, Issue:2 Topics: Abiraterone Acetate; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Tomography, X-Ray Computed; Treatment Outcome	2018
Radium-223 (Xofigo) with concurrent abiraterone or enzalutamide: predictive biomarkers of improved overall survival in a clinically advanced cohort. Current problems in cancer, 2019, Volume: 43, Issue:3 Topics: Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Chemoradiotherapy; Follow-Up Studies; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Rate	2019
Impact of timing of administration of bone supportive therapy on pain palliation from radium-223. Cancer treatment and research communications, 2019, Volume: 18 Topics: Androstenes; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Chemoradiotherapy; Follow-Up Studies; Humans; Male; Nitriles; Pain Management; Palliative Care; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Time Factors	2019
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population. International journal of cancer, 2020, 08-15, Volume: 147, Issue:4 Topics: Aged; Aged, 80 and over; Androstenes; Antineoplastic Agents; Benzamides; Bone Neoplasms; Chemoradiotherapy; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium; Registries; Taxoids	2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases, 2020, Volume: 23, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Denosumab; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Zoledronic Acid	2020
Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS. Clinical genitourinary cancer, 2021, Volume: 19, Issue:3 Topics: Aged; Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2021
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. The Prostate, 2021, Volume: 81, Issue:7 Topics: Aged; Androstenes; Benzamides; Bone Neoplasms; Combined Modality Therapy; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Rate; Veterans	2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population. Prostate cancer and prostatic diseases, 2021, Volume: 24, Issue:3 Topics: Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chemoradiotherapy; Docetaxel; Follow-Up Studies; Humans; Male; Nitriles; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Rate; Taxoids	2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without Cancer biotherapy & radiopharmaceuticals, 2021, Volume: 36, Issue:5 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Retrospective Studies; Survival Rate; Taxoids	2021
Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer. JAMA network open, 2021, 07-01, Volume: 4, Issue:7 Topics: Aged; Aged, 80 and over; Androstenes; Benzamides; Cognition; Drug Therapy; Humans; Male; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2021
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC. Future oncology (London, England), 2022, Volume: 18, Issue:1 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Benzamides; Bone Neoplasms; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2022
Combination therapy with radium-223 and enzalutamide in castration-resistant prostate cancer. Clinical advances in hematology & oncology : H&O, 2021, Volume: 19, Issue:12 Topics: Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium	2021
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model. International journal of molecular sciences, 2023, Jan-22, Volume: 24, Issue:3 Topics: Benzamides; Bone Neoplasms; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium	2023

chemdatabank.com